Details for New Drug Application (NDA): 211029
The generic ingredient in BROMFENAC SODIUM is bromfenac sodium. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the bromfenac sodium profile page.
Summary for 211029
| Tradename: | BROMFENAC SODIUM |
| Applicant: | Gland |
| Ingredient: | bromfenac sodium |
| Patents: | 0 |
Pharmacology for NDA: 211029
| Mechanism of Action | Cyclooxygenase Inhibitors |
Suppliers and Packaging for NDA: 211029
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BROMFENAC SODIUM | bromfenac sodium | SOLUTION/DROPS;OPHTHALMIC | 211029 | ANDA | Gland Pharma Limited | 68083-313 | 68083-313-01 | 1 BOTTLE, DROPPER in 1 CARTON (68083-313-01) / 1.7 mL in 1 BOTTLE, DROPPER |
| BROMFENAC SODIUM | bromfenac sodium | SOLUTION/DROPS;OPHTHALMIC | 211029 | ANDA | Fosun Pharma USA Inc. | 72266-142 | 72266-142-01 | 1 BOTTLE, DROPPER in 1 CARTON (72266-142-01) / 1.7 mL in 1 BOTTLE, DROPPER |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 0.09% ACID | ||||
| Approval Date: | Mar 17, 2020 | TE: | AT2 | RLD: | No | ||||
Complete Access Available with Subscription
